The global pharmaceutical contract development and manufacturing organization market size was valued at 92.1 billion in 2021 and is expected to reach 145.0 million by 2028, at a CAGR of 6.7% during the forecast period 2022 to 2028. A contract development and manufacturing company (CDMO) is a corporation that provides drug development and manufacturing services to the pharmaceutical sector....
The global Contract Pharmaceutical Manufacturing Market is estimated to be valued at US$ 101.45 Mn in 2023 and is expected to exhibit a CAGR of 7.7% over the forecast period from 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Contract pharmaceutical manufacturing refers to outsourcing the manufacturing of pharmaceutical products and services to...